204 related articles for article (PubMed ID: 9950250)
1. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor.
de Souza PE; Paim JF; Carvalhais JN; Gomez RS
J Oral Pathol Med; 1999 Feb; 28(2):54-8. PubMed ID: 9950250
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
Souza PE; Mesquita RA; Gomez RS
Oral Dis; 2000 Jan; 6(1):35-9. PubMed ID: 10673786
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical comparison of p53, Ki-67, CD68, vimentin, α-smooth muscle actin and alpha-1-antichymotry-psin in oral peripheral and central giant cell granuloma.
Kujan O; Al-Shawaf AZ; Azzeghaiby S; AlManadille A; Aziz K; Raheel SA
J Contemp Dent Pract; 2015 Jan; 16(1):20-4. PubMed ID: 25876945
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Analysis of p63 Expression in Giant Cell Tumour (GCT), Central Giant Cell Granuloma (CGCG) and Peripheral Giant Cell Granuloma (PGCG).
Nagar SR; Bansal S; Jashnani K; Sinha A; Desai RS
Head Neck Pathol; 2020 Sep; 14(3):733-741. PubMed ID: 31873936
[TBL] [Abstract][Full Text] [Related]
6. Central giant cell granulomas of the jaws: phenotype and proliferation-associated markers.
O'Malley M; Pogrel MA; Stewart JC; Silva RG; Regezi JA
J Oral Pathol Med; 1997 Apr; 26(4):159-63. PubMed ID: 9176789
[TBL] [Abstract][Full Text] [Related]
7. Mdm2 and the p53 pathway in human pituitary adenomas.
Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
[TBL] [Abstract][Full Text] [Related]
8. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors.
Wang C; Song Y; Peng B; Fan M; Li J; Zhu S; Bian Z
Oncol Rep; 2006 Mar; 15(3):589-94. PubMed ID: 16465417
[TBL] [Abstract][Full Text] [Related]
12. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
13. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the osteopontin in oral peripheral and central giant cell granuloma.
Aksakalli N
Indian J Pathol Microbiol; 2018; 61(1):18-21. PubMed ID: 29567878
[TBL] [Abstract][Full Text] [Related]
15. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1999; 50(1):9-16. PubMed ID: 10412269
[TBL] [Abstract][Full Text] [Related]
16. Cellular cannibalism in giant cells of central giant cell granuloma of jaw bones and giant cell tumors of long bones.
Sarode GS; Sarode SC; Gawande S; Patil S; Anand R; Patil SG; Patil P
J Investig Clin Dent; 2017 May; 8(2):. PubMed ID: 26991690
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
19. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
Xu QZ; Liu F; Lu DH; Yu SZ; Yang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
